.png){kind=logo}
Stock image for illustration purposes only - book cover, edition or condition may vary.
Utility of Bromelain and N-Acetylcysteine in Treatment of Peritoneal Dissemination of Gastrointestinal Mucin-Producing Malignancies
Amini, Afshin; Morris, David L.; Masoumi-Moghaddam, Samar
€ 128.24
FREE Delivery in Ireland
Description for Utility of Bromelain and N-Acetylcysteine in Treatment of Peritoneal Dissemination of Gastrointestinal Mucin-Producing Malignancies
Hardback. Num Pages: 248 pages, 2 black & white illustrations, 2 colour illustrations, 22 black & white tables, 3 colour. BIC Classification: MJCL; MMQ. Category: (P) Professional & Vocational. Dimension: 235 x 155 x 16. Weight in Grams: 543.
This volume will describe both growth-inhibitory and mucin-depleting effects of bromelain and N-acetylcysteine, on their own or in combination, in cancer. It will coherently review the pathophysiological aspects of the mucin glycoproteins in malignancies and provide an updated account of the status of bromelain and N-acetylcysteine in cancer therapy.
The volume will develop the idea of using these two drugs as a combination formulation for mucin-depleting effects.
Product Details
Format
Hardback
Publication date
2016
Publisher
Springer International Publishing AG Switzerland
Number of pages
248
Condition
New
Number of Pages
229
Place of Publication
Cham, Switzerland
ISBN
9783319285689
SKU
V9783319285689
Shipping Time
Usually ships in 15 to 20 working days
Ref
99-15
About Amini, Afshin; Morris, David L.; Masoumi-Moghaddam, Samar
Afshin Amini is MD, PhD at Department of Surgery, Research and Education Center, St. George Hospital, The University of New South Wales, Sydney, Australia. David L. Morris is Professor, The University of New South Wales, Head, Department of Surgery, St. George Hospital, NSW, Australia Samar Masoumi-Moghaddam is MD, PhD at Department of Surgery, Research and Education Center, St. ... Read more
Reviews for Utility of Bromelain and N-Acetylcysteine in Treatment of Peritoneal Dissemination of Gastrointestinal Mucin-Producing Malignancies